The BGMA’s Technical Director, Mr Paul Fleming, said the idea is to increase understanding of regulatory requirements and ensure that both generics makers and regulators are up to date on the latest information in each other’s spheres. While the MHRA said that they were ‘pleased’ with the industry initiative and were ‘keen to share knowledge and expertise so that companies can fully understand the regulatory environment in which they operate’. Topics that the forum intends to address include current MHRA approaches to inspection and the auditing that companies perform themselves.

The forum is open to BGMA members and associates and will bring together the MHRA, generics manufacturers and providers of manufacturing and quality control services, meeting three times a year. The first meeting is planned for 4 June 2014 and a second meeting is planned for 12 November 2014.

According to the BGMA, more than two thirds of all medicines dispensed by the UK’s National Health Service are generics, saving more than GBP 11 billion in England and Wales alone.

Related articles

UK plans to cut drug prices by up to 20%

UK accuses GSK of delaying generics

Permission granted to reproduce for personal and non-commercial use only. All other reproduction, copy or reprinting of all or part of any ‘Content’ found on this website is strictly prohibited without the prior consent of the publisher. Contact the publisher to obtain permission before redistributing.

Copyright – Unless otherwise stated all contents of this website are © 2014 Pro Pharma Communications International. All Rights Reserved.